Skip to main content
S

StrokeDx

StrokeDx develops portable, non-invasive stroke detection devices that utilize real-time blood flow imaging to identify ischemic and hemorrhagic strokes. This technology significantly reduces the time-to-treatment by enabling immediate triage and diagnosis, addressing the critical delays associated with traditional imaging methods like CT and MRI.

Los Angeles, United StatesFounded 202181K+ followers
Updated 20 months ago

Funding

$7.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current stroke diagnosis relies on CT and MRI scans, which are expensive, require specialized facilities, and cause delays in treatment initiation due to patient transport, waiting times, and image interpretation. Misdiagnosis can lead to incorrect treatment, potentially worsening patient outcomes due to the differing treatments for ischemic and hemorrhagic strokes.

Solution

StrokeDx is developing portable, non-invasive stroke detection devices that utilize real-time blood flow imaging to rapidly identify ischemic and hemorrhagic strokes. The handheld device aims to reduce time-to-treatment by enabling immediate triage and diagnosis at the point of care, eliminating the delays associated with traditional neuroimaging methods. By providing rapid differentiation between stroke types, StrokeDx intends to ensure patients receive the correct treatment sooner, improving outcomes and reducing morbidity and mortality. The technology offers a low-cost, high-accessibility solution for stroke detection.

Target Audience

The primary target audience includes medical professionals in emergency rooms, ambulances, and other point-of-care settings who require rapid and accurate stroke diagnosis, as well as hospitals and clinics seeking to improve stroke care efficiency and accessibility.

Features

  • Portable, handheld device for point-of-care stroke detection
  • Real-time blood flow imaging for rapid identification of ischemic and hemorrhagic strokes
  • Low-cost alternative to traditional CT and MRI scans
  • Aims to reduce time-to-treatment and improve patient outcomes
This profile is AI-generated and may contain inaccuracies.